Apr 21

New COVID-19 Research Investigating Plasma and Stem Cell Therapies, Anti-malarial, Antiviral and Antibiotic Meds while Vaccines are Developed

With up to 1 year before a successful vaccine may be developed, scientists are looking at existing medications as well as cellular therapies to combat COVID and the inflammation/cytokine (protein) storm that attacks the lungs and vital organs.     With Millions of people affected around the world, leading researchers are looking at everything from anti-malarial medication (Hydroxychloroquine) and antibiotics (Azithromycin or Z pack) to cell based therapies. Some cell based therapies include using “convalescent plasma” transfusion. I.e getting plasma from...

Apr 3

TOBI 2020 Goes Virtual

WATCH VIDEO - COVID Message: TOBI Founder, Dr. Steven Sampson, DO In light of the COVID-19 pandemic, we are adapting our Las Vegas in-person conference into a novel online experience. We invite you to join us at TOBI VIRTUAL 2020, June 12-13, for the largest online collaboration in the field of Orthobiologics. TOBI has always done live streaming, and will now feature NEW ways to learn, connect, and grow together, in the comfort and safety of your own home. We are excited...

Mar 21

Regulatory Compliance and More at TOBI XI!

New publication echoes TOBI 2020 theme: Regulatory Compliance, Clinical Data & Protocols. Platelet-Rich Plasma for Knee Osteoarthritis: Internet Marketing and Patient Education—An Appraisal of Content for Websites with the Greatest Search Engine Visibility This publication reviews 181 websites using 3 leading search engines, and discusses the importance of ethical patient information and marketing of orthobiologics. Based on results from the content analyzed, there is a remarkable difference between information accessed on non-private websites compared to private websites. Most notably, private...